Catalyst Pharmaceuticals (CPRX) Treasury Shares (2021)

Catalyst Pharmaceuticals (CPRX) has 10 years of Treasury Shares data on file, last reported at $752626.0 in Q4 2025.

• Quarterly Treasury Shares rose 6.16% year-over-year to $752626.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $752626.0 (up 6.16% YoY) and the FY2025 annual result came in at $752626.0, up 6.16% from the prior year.
• Treasury Shares grew to $752626.0 in Q4 2025, from $708960.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $854459.0 in Q4 2023 to a low of $67049.0 in Q1 2021.
• A 5-year average of $543072.2 and a median of $730730.0 in 2022 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2021 — Treasury Shares slumped 47.88% — and 2022, when it soared 512.59%.
• Tracing CPRX's Treasury Shares over 5 years: stood at $122839.0 in 2021, then soared by 512.59% to $752500.0 in 2022, then grew by 13.55% to $854459.0 in 2023, then fell by 17.03% to $708960.0 in 2024, then rose by 6.16% to $752626.0 in 2025.
• The last three Treasury Shares figures came in at $752626.0 (Q4 2025), $708960.0 (Q4 2024), and $854459.0 (Q4 2023), per Business Quant data.